Over-expression of miR-451a can enhance the sensitivity of breast cancer cells to tamoxifen by regulating 14-3-3ζ, estrogen receptor α, and autophagy

Life Sciences

Volumn 149, Issue , 2016, Pages 104-113

  Liu, Zhen Ru ^a   Song, Yi ^b   Wan, Li Hong ^a   Zhang, Yuan Yuan ^a   Zhou, Li Mimg ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

14 3 3 ; Autophagy; Breast cancer; ER ; MiR 451a; Resistance; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 451A; PROTEIN KINASE B; SMALL INTERFERING RNA; STRATIFIN; TAMOXIFEN; UNCLASSIFIED DRUG; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ESTROGEN RECEPTOR ALPHA, HUMAN; MIRN451 MICRORNA, HUMAN; PROTEIN 14 3 3;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ELECTRON MICROSCOPY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MCF 7 CELL LINE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BREAST NEOPLASMS; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY;

14-3-3 PROTEINS; ANTINEOPLASTIC AGENTS, HORMONAL; AUTOPHAGY; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICRORNAS; TAMOXIFEN;

EID: 84961590445     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.02.059     Document Type: Article

References (29)

1. A. Bergamaschi, and B.S. Katzenellenbogen Tamoxifen downregulation of miR-451 increase 14-3-3ζand promote breast cancer cell survival and endocrine resistance Oncogene 31 2012 39 47
2. A. Bergamaschi, B.L. Christensen, and B.S. Katzenellenbogen Reversal of endocrine resistance in breast cancer: Interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis Breast Cancer Res. 13 2011 R70
3. N. Chen, and J. Debnath Autophagy and tumorigenesis FEBS Lett. 584 2010 1427 1435
4. E.A. Corcelle, P. Puustinen, and M. Jaattela Apoptosis and autophagy: Targeting autophagy signalling in cancer cells-'trick or treats'? FEBS J. 276 2009 6084 6096
5. Y. Chang, W. Yan, X. He, L. Zhang, C. Li, H. Huang, G. Nace, D.A. Geller, J. Lin, and A. Tsung miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions Gastroenterology 143 2012 177 187
6. I.J. De Vries-van Leeuwen, Pereira D. da Costa, K.D. Flach, S.R. Piersma, C. Haase, D. Bier, Z. Yalcin, R. Michalides, K.A. Feenstra, C.R. Jiménez, and et al. Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface Proc. Natl. Acad. Sci. U. S. A. 110 2013 8894 8899
7. S. Dong, S. Kang, S. Lonial, H.J. Khoury, J. Viallet, and J. Chen Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibitor GX15-070 Leukemia 22 2008 572 577
8. C.H. Ford, M. Al-Bader, B. Al-Ayadhi, and I. Francis Reassessment of estrogen receptor expression in human breast cancer cell lines Anticancer Res. 31 2011 521 527
9. J. Frasor, E.C. Chang, B. Komm, C.Y. Lin, V.B. Vega, E.T. Liu, L.D. Miller, J. Smeds, J. Bergh, and B.S. Katzenellenbogen Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome Cancer Res. 66 2006 7334 7340
10. L.B. Frankel, J. Wen, M. Lees, M. Høyer-Hansen, T. Farkas, A. Krogh, M. Jäättelä, and A.H. Lund microRNA-101 is a potent inhibitor of autophagy EMBO 30 2011 4628 4641
11. R. García-Becerra, N. Santos, L. Díaz, and J. Camacho Mechanism of resistance to endocrine therapy in breast cancer: Focus on signaling pathways, miRNAs and genetically based resistance Int. Mol. Sci. 14 2012 108 145
12. D.U. Kim, J.W. Min, Y.M. Kim, and M.C. Myung-Chul Chang Estimating the risks and benefits of tamoxifen for prophylactic breast cancer chemoprevention in Korea J. Breast Cancer 15 2013 51 56
13. C. Kim, G. Tang, K.L. Pogue-Geile, J.P. Costantino, F.L. Baehner, J. Baker, M.T. Cronin, D. Watson, S. Shak, O.L. Bohn, and et al. Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor positive breast cancer J. Clin. Oncol. 29 2011 4160 4167
14. K. Luan, J. Yu, R. Yao, B. Zhang, and C. Sun Construction of lentiviral vector carrying TRAIL gene and its expression in hepatocarcinoma cells Prog. Mod. Biomed. 12 2012 1639 1643
15. J. Lu, H. Guo, W. Treekitkarnmongkol, P. Li, J. Zhang, B. Shi, C. Ling, X. Zhou, T. Chen, P.J. Chiao, and et al. 14-3-3Zeta cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition Cancer Cell 16 2009 195 207
16. T.W. Miller Endocrine resistance: What do we know? Am. Soc. Clin. Oncol. Educ. Book 2013 e37
17. A.A. Memon, B.S. Sorensen, P. Meldgaard, L. Fokdal, T. Thykjaer, and E. Nexo The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: A study in bladder cancer patients Br. J. Cancer 94 2006 1703 1709
18. S. Masaki, R. Ohtsuka, Y. Abe, K. Muta, and T. Umemura Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis Biochem. Biophys. Res. Commun. 364 2007 509 514
19. D.K. Morrison The 14-3-3 proteins: Integrators of diverse signaling cues that impact cell fate and cancer development Trends Cell Biol. 19 2009 16 23
20. C.L. Neal, and D. Yu 14-3-3ζ as a prognostic marker and therapeutic target for cancer Expert Opin. Ther. Targets 14 2010 1343 1354
21. N. Othman, and N.H. Nagoor The role of microRNA in the regulation of apoptosis of in lung cancer and its application of cancer treatment BioMed. Res. Int. 3180308 2014
22. M.M. Regan, P. Neven, A. Giobbie-Hurder, A. Goldhirsch, B. Ejlertsen, L. Mauriac, J.F. Forbes, I. Smith, I. Láng, A. Wardley, and et al. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: BIG 1-98 randomised clinical trial at 8.1 years median follow-up Lancet Oncol. 12 2011 1101 1108
23. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA Cancer J. Clin. 63 2013 11 30
24. K. Sun, H.J. Deng, S.T. Lei, J.Q. Dong, and G.X. Li miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened World J. Gastroenterol. 19 2013 2197 2207
25. V.K. Weerasekara, D.J. Panek, D.G. Broadbent, J.B. Mortenson, A.D. Mathis, G.N. Logan, J.T. Prince, D.M. Thomson, J.W. Thompson, and J.L. Andersen Metabolic-stress-induced rearrangement of the 14-3-3ζ interactome promotes autophagy via ULK1-and AMPK-regulated 14-3-3ζ interaction with phosphorylated Atg9 Mol. Cell. Biol. 34 2014 4379 4388
26. H. Weidberg, E. Shvets, and Z. Elazar Biogenesis and cargoselectivity of autophagosomes Annu. Rev. Biochem. 80 2011 125 156
27. H. Yamashita, Y. Yando, M. Nishio, Z. Zhang, M. Hamaguchi, K. Mita, S. Kobayashi, Y. Fujii, and H. Iwase Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer Breast Cancer 13 2006 74 83
28. H. Zhu, H. Wu, X. Liu, B.R. Evans, D.J. Medina, C.G. Liu, and G.M. Yang Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells Biochem. Pharmacol. 76 2008 582 588
29. Z. Zou, L. Wu, H. Ding, Y. Wang, Y. Zhang, X. Chen, X. Chen, C.Y. Zhang, Q. Zhang, and K. Zen MicroRNA-30a sensitizes tumor cells to cisplatinum via suppressing beclin 1-mediated autophagy J. Biol. Chem. 287 2012 4148 4156